Medici Investment
VC Fund
Medici Investment is a VC fund focused on Biotechnology and Information Technology. Venture Capital firm in South Korea.
- Total investments:
- 38
- Last investment:
- Lead investor:
- 18%
Last updated:
For AI agents: llms.txt
Industries Medici Investment invests in
Stages Medici Investment invests in
Countries Medici Investment invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $861k–$18M
- Series B
- $7.8M–$27M
- Series C
- $2.9M–$250M
Investment Focus
Industry
- Biotechnology 7 (18%)
- Information Technology 7 (18%)
- Software 6 (16%)
- Medical 5 (13%)
- Artificial Intelligence 5 (13%)
Stage
- Series A 13 (34%)
- Series C 8 (21%)
- Series B 6 (16%)
- Seed 5 (13%)
- Venture - Series Unknown 5 (13%)
Country
- South Korea 32 (84%)
- Canada 1 (3%)
- Singapore 1 (3%)
- United States 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jin-hwan Bae
CEO
|
CEO | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Destin Power manufactures power conditioning products designed to improve energy management and safety. The company created the ESS system by utilizing core power electronics technology such as control technology for energy storage systems, static and dynamic grid support technology, and micro-grid inverter technology. | $7.4M / Venture - Series Unknown / Jul 30, 2026 | ||
| MID specializes in the development, testing, and production of space-related components. | $10.8M / Series A / Jul 29, 2026 | ||
| RebuilderAI is a 3D AI vision technology company for manufacturing, design, gaming, and entertainment. | $3.1M / Seed / Nov 13, 2025 | ||
| First Lab designs and manufactures ultrasonic equipment for various industries, including nano emulsification/dispersion, non-surface-forming materials, protein extraction, and water treatment. They research and develop innovative nano materials and processing technologies, producing high-quality, uniform materials and efficiently treatingtoxic substances. | $2.1M / Seed / Nov 07, 2025 | ||
| AI chip architects are often inattentive to advanced deep learning features and requirements because they believe software stacks between their silicon and algorithms can provide effective abstract layers. We disagree. We do not think such naively designed chips can efficiently utilize expensive custom silicon resources. The more native hardwaresupports are enabled, the higher performance is achieved.Rebellions Inc is building genuine AI accelerators by bi-directionally bridging the gap between underlying silicon architectures and deep learning algorithms. We push algorithm boundaries to better exploit silicon budgets, while re-architecting AI processors to incorporate sophisticated deep learning features through silicon-dedicated DL kernels.Our goal is to deliver a domain-specific AI processor along with its optimized software. This approach, together with our unique decentralized programming model, will enable customers to arm with the most powerful yet energy-efficient AI hardware as well as seamless integration. | $250M / Series C / Sep 30, 2025 | ||
| MBD is a biotechnology company that specializes in 3D cell culture platforms. | $11.9M / Series C / Aug 14, 2025 | ||
| FRT Robotics develops wearable robotics and exoskeleton solutions that support workers in industrial environments. The company builds wearable robots, along with AI-based monitoring software, for industries such as construction, logistics, manufacturing, and healthcare. FRT Robotics focuses on human-robot collaboration through industrialexoskeleton technology. | $731K / Series A / Jun 11, 2025 | ||
| Storelink is an open market optimization platform that analyzes and processes accurate online sales data. | $2.9M / Series C / Nov 28, 2024 | ||
| BONABANK is an ERP software development company. | $8.3M / Venture - Series Unknown / Sep 04, 2023 | ||
| STEPPAY is a Korean subscription payment platform. | $3.7M / Seed / Jul 06, 2023 | ||
| See all 38 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Medici Investment invest in?
Medici Investment invests primarily in Biotechnology, Information Technology and Software startups, most often at Series A and Series C stage. Most of the 38 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Medici Investment's check size?
Medici Investment typically joins rounds of $861k–$18M at Series A, $7.8M–$27M at Series B and $2.9M–$250M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Medici Investment participates in.
How do I contact Medici Investment?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Medici Investment?
The team at Medici Investment includes Jin-hwan Bae (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
